Stock Scorecard



Stock Summary for Milestone Pharmaceuticals Inc (MIST) - $1.80 as of 3/28/2024 2:38:38 PM EST

Total Score

6 out of 29

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for MIST

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for MIST

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for MIST

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2

Bonus Criteria for MIST

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Latest News for for MIST

Milestone Pharmaceuticals Announces Resubmission of New Drug Application for Etripamil for Treatment in Paroxysmal Supraventricular Tachycardia - Milestone Pharmaceuticals ( NASDAQ:MIST ) 3/28/2024 11:00:00 AM
Milestone Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Regulatory and Corporate Update 3/21/2024 11:14:00 AM
Why Okta Shares Are Trading Higher By Around 24%; Here Are 20 Stocks Moving Premarket - Okta ( NASDAQ:OKTA ) 2/29/2024 1:04:00 PM
Milestone Pharmaceuticals Announces Pricing of $30.0 Million Public Offering of Common Shares and Pre-Funded Warrants 2/29/2024 12:00:00 PM
Milestone Pharmaceuticals Announces Proposed Public Offering of Common Shares and Pre-Funded Warrants - Milestone Pharmaceuticals ( NASDAQ:MIST ) 2/28/2024 9:37:00 PM
Milestone Pharmaceuticals Announces Proposed Public Offering of Common Shares and Pre-Funded Warrants 2/28/2024 9:37:00 PM
Why Milestone Pharmaceuticals ( MIST ) Stock Is Rising - Milestone Pharmaceuticals ( NASDAQ:MIST ) 2/26/2024 2:50:00 PM
MILESTONE ALERT: Bragar Eagel & Squire, P.C. is Investigating Milestone Pharmaceuticals Inc. on Behalf of Milestone Stockholders and Encourages Investors to Contact the Firm - Milestone Pharmaceuticals ( NASDAQ:MIST ) 1/19/2024 2:00:00 AM
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Milestone Pharmaceuticals Inc.- MIST - Milestone Pharmaceuticals ( NASDAQ:MIST ) 1/18/2024 10:23:00 PM
Milestone Pharmaceuticals Investigated by Block & Leviton For Potential Securities Law Violations: Investors Who Have Lost Money Are Encouraged to Contact the Firm - Milestone Pharmaceuticals ( NASDAQ:MIST ) 1/18/2024 6:23:00 PM

Financial Details for MIST

Company Overview

Ticker MIST
Company Name Milestone Pharmaceuticals Inc
Country USA
Description Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular drugs. The company is headquartered in Montral, Canada.
Sector Name LIFE SCIENCES
Industry Name PHARMACEUTICAL PREPARATIONS
Most Recent Quarter 12/31/2023
Next Earnings Date 5/9/2024

Stock Price History

Last Day Price 1.80
Last Day Price Updated 3/28/2024 2:38:38 PM EST
Last Day Volume 0
Average Daily Volume 508,556
52-Week High 4.49
52-Week Low 1.33
Last Price to 52 Week Low 35.34%

Valuation Measures

Trailing PE N/A
Industry PE 100.07
Sector PE 60.76
5-Year Average PE -4.11
Free Cash Flow Ratio 1.45
Industry Free Cash Flow Ratio 12.70
Sector Free Cash Flow Ratio 31.04
Current Ratio Most Recent Quarter 10.11
Total Cash Per Share 1.24
Book Value Per Share Most Recent Quarter 0.39
Price to Book Ratio 5.70
Industry Price to Book Ratio 5.57
Sector Price to Book Ratio 21.66
Price to Sales Ratio Twelve Trailing Months 95.67
Industry Price to Sales Ratio Twelve Trailing Months 13.94
Sector Price to Sales Ratio Twelve Trailing Months 8.77

Share Statistics

Total Shares Outstanding 53,150,000
Market Capitalization 95,670,000
Institutional Ownership N/A

Dividends

Ex-Dividend Date N/A
Last Dividend Amount 0.00
Current Dividend Amount 0.00
Dividend Aristocrat? False
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth -2.22%
Reported EPS 12 Trailing Months -1.39
Reported EPS Past Year -1.39
Reported EPS Prior Year -1.37
Net Income Twelve Trailing Months -59,685,000
Net Income Past Year -59,685,000
Net Income Prior Year -58,388,000
Quarterly Revenue Growth YOY -100.00%
5-Year Revenue Growth 0.00%

Balance Sheet

Total Cash Most Recent Quarter 66,000,000
Total Cash Past Year 66,000,000
Total Cash Prior Year 64,500,000
Net Cash Position Most Recent Quarter 16,228,000
Net Cash Position Past Year 16,228,000
Long Term Debt Past Year 49,772,000
Long Term Debt Prior Year 0
Total Debt Most Recent Quarter 49,772,000
Equity to Debt Ratio Past Year 0.25
Equity to Debt Ratio Most Recent Quarter 0.25
Total Stockholder Equity Past Year 16,771,000
Total Stockholder Equity Prior Year 66,348,000
Total Stockholder Equity Most Recent Quarter 16,771,000

Options

Put/Call Ratio 0.00
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -0.02
MACD Signal -0.05
20-Day Bollinger Lower Band 0.82
20-Day Bollinger Middle Band 1.95
20-Day Bollinger Upper Band 3.08
Beta 1.77
RSI 56.45
50-Day SMA 2.75
200-Day SMA 5.23

System

Modified 3/29/2024 1:21:11 AM EST